You can listen to the first episode of this three-part series here.

GLP-1 medications to treat diabetes, obesity and several other illnesses have exploded in popularity since Ozempic was approved for use in Canada back in 2018. Ozempic and Wegovy, the GLP-1s which contain semaglutide, are the third-most prescribed drug in Canada, and by far the best-selling one.

Chris Hannay, The Globe’s business of health reporter, will explain why the introduction of generic semaglutide will mean lower prices and more options for Canadians. And we’ll explore access to these drugs with The Globe’s health reporter Kelly Grant on who gets their GLP-1 covered by their insurance – and who doesn’t.

Plus, Globe audio producer Kasia Mychajlowycz leads us on a journey to understand just how the virtual pharmacies advertised all over her social media feed are vetting people who want Ozempic prescriptions.

The next episode and final episode of Skinny, Inc. is next Monday, March 9.

You can contact the National Eating Disorders Information Centre at their toll-free hotline at 1-866-NEDIC-20 or visit their website.

Questions? Comments? Ideas? E-mail us at thedecibel@globeandmail.com

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Months before the mass shooting in Tumbler Ridge, B.C., earlier this month, the shooter was banned from OpenAI, the company behind ChatGPT, for violating its usage policy. The Wall Street Journal, which first reported this, said that the interactions with ChatGPT were describing scenarios involving gun violence. That has furthered calls for the Canadian government to regulate AI companies and their products – but there are challenges.

Taylor Owen is an associate professor at McGill and founding director of McGill’s Centre for Media, Technology and Democracy. He’s also host of The Globe and Mail podcast Machines Like Us. He’ll tell us what responsibility companies have to report concerning or violent content, and what the government is up against in trying to regulate AI.

Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On Tuesday night, U.S. President Donald Trump touted his tariff regime, after a Supreme Court decision that severely limited his ability to impose tariffs. Now countries trading with the U.S. are left with even more uncertainty about what will come next.

Jason Kirby is a staff reporter for The Globe’s Report on Business. He explains what the court ruling means for Canada, what other tariffs could be coming our way soon and who have been the winners and losers in the trade war over the last year.

Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.